Spyre Therapeutics SYRE Stock Analysis Climbs 796 Eyes on 7552 20260520 urbangro UGRO Q3 2025 Earnings Miss EPS 948 vs 004 Expected Mediaco Holding MDIA Reports Q3 2023 In Line Steady Performance Continues Intellinetics INLX Q1 2026 Disappoints EPS 021 Below 005 Views Traders Bet on IonQ and Anduril as Next Potential US Government Equity Targets Putins Nuclear Doctrine Update Sparks Market Jitters US Futures Bond Yields Decline Salesforce Shares Decline on Soft Revenue Outlook Amid Persistent AI Disruption Concerns Mercury Reaches 52 Billion Valuation in Latest Funding Round Defying Fintech Downturn PL Capital Highlights Growth Potential in Adani Group Stocks Vickers Insider Trading Report Highlights Shifts in Corporate Sentiment for Late May